Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026
Get Alerts BMY Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 4.3%
Revenue Growth %: -4.6%
Join SI Premium – FREE
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at the Bank of America Securities Healthcare Conference 2026 on Thursday, May 14, 2026.
The company will take part in a fireside chat beginning at 8:40 a.m. PT/11:40 a.m. ET.
Investors and the general public are invited to listen to the session by visiting http://investor.bms.com. An archived edition of the session will be available following its conclusion.
About Bristol Myers Squibb: Transforming Patients’ Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20260506042592/en/
Media:
[email protected]
Investors:
[email protected]
Source: Bristol Myers Squibb
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Comstock Earns Russell 3000® Inclusion, Expanding Institutional Investor Reach
- Dialogica Announces Inaugural Board of Advisors
- Inframark Selected to Operate and Maintain Hull, Massachusetts Wastewater Infrastructure
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share